BioMr. Eklund joined the Childs Family Office in January 2011 with a focus on Venture Capital investments. Investment portfolio holdings include BioHaven Pharmaceuticals, Kleo Pharmaceuticals, Melinta Therapeutics, Prevention Pharmaceuticals, Stemedica Cell Technologies, Basin Holdings and J.W. Childs Asia Equities. Prior to 2011, Mr. Eklund was Managing Director/Head of Corporate Strategy and M&A at New York Life Inves ....
Access "Christopher Eklund" Work Experience (Current/Past), Board Seats, Joined Date, Contact Details - Emailid/Phone and Investments (If any)
in one connected platform (AcquityData).
We use essential cookies to run this site (like keeping you signed in), and — only with your consent — analytics cookies to understand how the site is used. See our
Privacy Policy for details on what we collect and why.